|
시장보고서
상품코드
2148302
RWE(Real World Evidence) 시장 : 구성요소별, 데이터 소스별, 용도별, 치료 분야별, 최종사용자별, 지역별Real World Evidence Market, By Component, By Data Source, By Application, By Therapeutic Area, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
RWE(Real World Evidence) 시장은 2026년에 46억 2,580만 달러 규모로 추정되며, 2033년까지 104억 2,070만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 12.3%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 46억 2,580만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 12.30% | 2033년 시장 규모 예측: | 104억 2,070만 달러 |
리얼 월드 에비던스(RWE)란, 전자건강기록, 보험 청구 데이터, 레지스트리, 환자 생성 데이터, 디지털 헬스 기술 등 기존의 무작위 대조 시험 이외의 경로를 통해 수집된 리얼 월드 데이터(RWD)를 분석하여 도출된 임상적 근거를 말합니다. 전 세계 RWE 시장은 다양한 환자 집단과 일상적인 임상 현장에서 의료 제품의 유효성에 대한 인사이트를 제공함으로써, 헬스케어 및 생명과학 분야에 혁신을 가져오고 있습니다.
가치 기반 의료 및 정밀 의료의 보급이 확대됨에 따라, 임상 개발, 규제 당국의 의사결정, 시판 후 조사에서 RWE의 전략적 역할은 점점 더 강화되고 있습니다. 미국 식품의약국(FDA) 및 유럽의약품청(EMA)과 같은 규제 당국은 의약품 개발 및 규제 시스템에서 RWE를 점점 더 적극적으로 도입하고 있으며, 승인, 적응증 확대, 승인 후 증거 생성 과정에서 RWE를 활용할 수 있게 되었습니다.
시장 역학
세계 RWE(Real World Evidence) 시장은 전자건강기록(EHR) 및 의료 정보 기술의 활용 확대, 비교 유효성 및 비용 대비 효과에 대한 증거 수요 증가, 그리고 지속적인 결과 추적이 필요한 만성 질환의 유병률 증가에 힘입어 성장하고 있습니다. 인공지능(AI) 및 기계 학습(ML)의 통합이 진행됨에 따라 대규모의 복잡한 실세계 데이터세트를 분석하는 능력이 향상되고 있는 한편, 지원적인 규제 덕분에 의약품 개발 및 의료적 의사결정 과정에서 RWE의 활용이 촉진되고 있습니다.
그러나 시장에는 데이터 개인정보 보호 및 보안 요건, 데이터 품질의 편차, 표준화 및 상호 운용성 문제, 숙련된 RWE 전문가 부족 등 많은 제약이 존재합니다. 그럼에도 불구하고 아시아태평양, 라틴아메리카, 중동 전역에서 의료기기 평가, 의료기술 평가, 맞춤형 의료 및 의료 디지털화 분야에서 RWE의 활용이 확대되고 있으며, 새로운 데이터 소스와 시장 기회가 창출되는 등 큰 비즈니스 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략)를 바탕으로 전 세계 리얼 월드 에비던스(RWE) 시장의 주요 기업 개요를 소개하고 있습니다.
- 본 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 세계 리얼 월드 에비던스 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 RWE(Real World Evidence) 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 RWE(Real World Evidence) 시장 : 구성요소별, 2021-2033년
제5장 세계의 RWE(Real World Evidence) 시장 : 데이터 소스별, 2021-2033년
제6장 세계의 RWE(Real World Evidence) 시장 : 용도별, 2021-2033년
제7장 세계의 RWE(Real World Evidence) 시장 : 치료 분야별, 2021-2033년
제8장 세계의 RWE(Real World Evidence) 시장 : 최종사용자별, 2021-2033년
제9장 세계의 RWE(Real World Evidence) 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고문헌 및 조사 방법
KSM 26.10.22Real World Evidence Market is estimated to be valued at USD 4,625.8 Mn in 2026 and is expected to reach USD 10,420.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,625.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.30% | 2033 Value Projection: | USD 10,420.7 Mn |
Real World Evidence (RWE) is clinical evidence that comes from analyzing real world data (RWD) gathered outside of traditional randomized controlled trials such as electronic health records, claims data, registries, patient-generated data, and digital health technologies. The global RWE market is changing healthcare and life sciences by providing insights into the performance of medical products across different patient populations and in routine clinical settings.
The increasing adoption of value-based care and precision medicine is strengthening the strategic role of RWE in clinical development, regulatory decision making and post-market surveillance. Regulatory agencies such as the U.S. FDA and European Medicines Agency (EMA) are increasingly embracing RWE in drug development and regulatory systems, enabling its use in approvals, label expansions and post-approval evidence generation.
Market Dynamics
The global real world evidence market is driven by the increasing use of electronic health records (EHRs) and health information technologies, the increasing demand for evidence on comparative effectiveness and cost-efficiency, and the growing prevalence of chronic diseases that require continuous tracking of outcomes. The increasing integration of artificial intelligence (AI) and machine learning (ML) is enhancing the analysis of large and complex real-world datasets, while supportive regulations are promoting the use of RWE in drug development and healthcare decision-making.
However, a number of constraints are present in the market, such as data privacy and security needs, inconsistent data quality, standardization and interoperability alongside a shortage of skilled RWE professionals. Nevertheless, significant opportunities exist with the increasing use of RWE in medical device evaluation, health technology assessment and personalized medicine and healthcare digitization across Asia-Pacific, Latin America and the Middle East creating new data sources and market opportunities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global real world evidence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Komodo Health, Inc., Merative, Optum, Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, Oracle Corporation, SAS Institute Inc., Aetion, Inc., and TriNetX, LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global real world evidence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world evidence market
Market Segmentation
- Component Insights (Revenue, USD Mn, 2021 - 2033)
- Data Sets
- Analytics Services
- Software and Platforms
- Others
- Data Source Insights (Revenue, USD Mn, 2021 - 2033)
- Electronic Health Records (EHRs)
- Claims and Billing Data
- Clinical Registries
- Pharmacy and Prescription Data
- Patient-Generated Health Data
- Wearable and Digital Health Data
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Drug Development and Clinical Trials
- Regulatory Decision-Making
- Post-Market Surveillance
- Comparative Effectiveness Research
- Health Economics and Outcomes Research
- Safety and Risk Management
- Market Access and Reimbursement
- Others
- Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Cardiovascular Diseases
- Neurology
- Immunology
- Infectious Diseases
- Respiratory Diseases
- Rare Diseases
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Healthcare Providers
- Contract Research Organizations (CROs)
- Regulatory Authorities
- Payers and Health Insurance Providers
- Academic and Research Institutions
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Komodo Health, Inc.
- Merative
- Optum, Inc.
- ICON plc
- Syneos Health, Inc.
- Parexel International Corporation
- Oracle Corporation
- SAS Institute Inc.
- Aetion, Inc.
- TriNetX, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Real World Evidence Market, By Component
- Global Real World Evidence Market, By Data Source
- Global Real World Evidence Market, By Application
- Global Real World Evidence Market, By Therapeutic Area
- Global Real World Evidence Market, By End User
- Global Real World Evidence Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Component Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Real World Evidence Market, By Component, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Data Sets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Analytics Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Software and Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Real World Evidence Market, By Data Source, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Electronic Health Records (EHRs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Claims and Billing Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinical Registries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pharmacy and Prescription Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Benign Prostatic Hyperplasia (BPH) Patient-Generated Health Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Wearable and Digital Health Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Real World Evidence Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Development and Clinical Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Regulatory Decision-Making
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Post-Market Surveillance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Comparative Effectiveness Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Health Economics and Outcomes Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Safety and Risk Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Market Access and Reimbursement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Real World Evidence Market, By Therapeutic Area, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Real World Evidence Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Regulatory Authorities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Payers and Health Insurance Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Real World Evidence Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Komodo Health, Inc.
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merative
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Optum, Inc.
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health, Inc.
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International Corporation
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oracle Corporation
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- SAS Institute Inc.
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aetion, Inc.
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
- TriNetX, LLC
- Company Highlights
- Component Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
